Further insights into Alzheimer disease pathogenesis

Nature Reviews Neurology

Volumn 9, Issue 2, 2013, Pages 65-66

  Weiner, Michael W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; BAPINEUZUMAB; BETA SECRETASE 1; SOLANEZUMAB; TAU PROTEIN; AMYLOID BETA PROTEIN; MONOCLONAL ANTIBODY;

ALZHEIMER DISEASE; AMINO ACID SUBSTITUTION; AMYLOID PRECURSOR PROTEIN GENE; AUTOSOMAL DOMINANT DISORDER; BRAIN ATROPHY; CAUDATE NUCLEUS; DEMENTIA; DENTATE GYRUS; ENTORHINAL CORTEX; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; GLUCOSE METABOLISM; HIPPOCAMPUS; HUMAN; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NONHUMAN; ONSET AGE; PATHOGENESIS; PRECUNEUS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN FOLDING; PROTEIN MISFOLDING; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; BRAIN; DISEASE COURSE; GENETICS; MUTATION; PATHOLOGY; PHASE 3 CLINICAL TRIAL (TOPIC); PHYSIOLOGY; TREATMENT FAILURE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANTIBODIES, MONOCLONAL; BRAIN; CLINICAL TRIALS, PHASE III AS TOPIC; DEMENTIA; DISEASE PROGRESSION; HUMANS; MUTATION; TAU PROTEINS; TREATMENT FAILURE;

MLCS; MLOWN;

EID: 84873742707     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2012.275     Document Type: Review

References (8)

1. Bateman, R. J. et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N. Engl. J. Med. 367, 795-804 (2012).
2. Buchhave, P. et al. Cerebrospinal fluid levels of β amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia. Arch. Gen. Psychiatry 69, 98-106 (2012).
3. Jonsson, T. et al. A mutation in APP protects against Alzheimer's disease and age-related cognitive decline. Nature 488, 96-99 (2012).
4. Braak, H., Thal, D. R., Ghebremedhin, E. & Del Tredici, K. Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J. Neuropathol. Exp. Neurol. 70, 960-969 (2011).
5. Liu, L. et al. Trans-synaptic spread of tau pathology in vivo. PLoS ONE 7, e31302 (2012).
6. de Calignon, A. et al. Propagation of tau pathology in a model of early Alzheimer's disease. Neuron 73, 685-697 (2012).
7. Stohr, J. et al. Purified and synthetic Alzheimer's amyloid beta (Aβ) prions. Proc. Natl Acad. Sci. USA 109, 11025-11030 (2012).
8. Prusiner, S. B. Cell biology. A unifying role for prions in neurodegenerative diseases. Science 336, 1511-1513 (2012).